ONCOLYS BIOPHARMA
Oncolys BioPharma Inc. is a biopharmaceutical company. The Company operates in two business segments. Pharmaceutical business segment is engaged in the research, development, manufacture and marketing of pharmaceuticals. Diagnostic reagents business segment is engaged in the research, development, manufacture and marketing of diagnostic reagents and equipment, as well as the provision of inspection service. The Company's main pipeline includes OBP-601 for the treatment of human immunodeficiency ... virus (HIV) infection; OBP-301 (Telomelysin), an oncolytic virus; OBP-801, an epigenetic anticancer drug; OBP-1101 (Telomescan F35), a virus for blood floating cancer cells (CTC) detection; OBP-401 (Telomescan), a virus for inflammatory disease detection, and OBP-1102, a virus for leukemia detection, among others.
ONCOLYS BIOPHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-03-18
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.oncolys.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Content Delivery Network Font Awesome Microsoft Exchange Online Office 365 Mail JsDelivr Microsoft Azure DNS BootstrapCDN Amazon Route 53 TrendMicro Email Services
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-02-19 | Unleash Immuno Oncolytics | Oncolys BioPharma investment in Venture Round - Unleash Immuno Oncolytics | 3 M USD |
| 2017-03-31 | Precision Virologics | Oncolys BioPharma investment in Seed Round - Precision Virologics | 500 K USD |
Official Site Inspections
http://www.oncolys.com
- Host name: www.oncolys.com
- IP address: 140.227.145.246
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Oncolys BioPharma"
Company Profile - About | Oncolys BioPharma Inc.
Mar 18, 2004 Oncolys USA Inc. 343 Thornall Street, Suite 505 Edison, NJ 08837 General Phone number: +1 732 -662-9880 President:Talia Biran: OPA Therapeutics Inc. Frank Tufaro: About …See details»
Oncolys BioPharma - Crunchbase Company Profile
Oncolys BioPharma Inc. is a biopharmaceutical company. The Company operates in two business segments. Pharmaceutical business segment is …See details»
CEO Message - About | Oncolys BioPharma Inc.
In April 2019, Oncolys entered into a license agreement with Chugai Pharmaceuticals for Telomelysin (OBP-301), a proprietary oncolytic adenovirus immunotherapy candidate for various cancers. Although this is a big milestone …See details»
Oncolys BioPharma Inc. Management Team | Org Chart
The Oncolys BioPharma Inc. management team includes Yasuo Urata (President and CEO), Tali Biran (President of Oncolys Usa), and David Sans (Vice President of Corporate and Business …See details»
Oncolys BioPharma Company Profile | Management and …
Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the …See details»
Oncolys BioPharma Inc. - LinkedIn
Oncolys BioPharma Inc. is a Tokyo-based bioventure established in Japan in March 2004. Its mission is to contribute to the advancement of medical science in the world through bringing innovation ...See details»
Oncolys BioPharma, Inc. - Drug pipelines, Patents, Clinical trials ...
Mar 7, 2025 Komipharm International Co., Ltd., Oncolys BioPharma, Inc., MAIA Biotechnology, Inc., Medigen Biotechnology Corp., and Ultimovacs ASA are some of the companies with …See details»
Oncolys BioPharma Company Profile - Office Locations ... - Craft
Oct 29, 2024 Oncolys BioPharma is a company that develops therapy and diagnostics in cancer treatment. Its pharmaceutical products include oncolytic viruses, molecular target drugs, and …See details»
Oncolys BioPharma Inc. (4588.T) - Yahoo Finance
See the company profile for Oncolys BioPharma Inc. (4588.T) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Oncolys BioPharma Company Description - Stock Analysis
Sep 18, 2024 Oncolys BioPharma Inc. has various licensing agreements with Okayama University, Osaka University, Kyoto Prefectural University of Medicine, Kagoshima University, …See details»
Oncolys BioPharma - VentureRadar
Oncolys BioPharma continuously evolve its business to develop breakthrough therapy and diagnostics in cancer treatment from early to late stage, including early detection, loco-regional …See details»
Oncolys BioPharma Inc. || オンコリス バイオ ファーマ 株式会社
新規抗がん剤テロメライシン（Telomelysin）を開発しているオンコリスバイオファーマのHPです。See details»
ONCOLYS USA INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ONCOLYS USA INC. of Edison, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Oncolys BioPharma - Funding, Financials, Valuation & Investors
Oncolys BioPharma is registered under the ticker TYO:4588 . Oncolys BioPharma has made 2 investments. Their most recent investment was on Feb 19, ... Which industries has this …See details»
Oncolys BioPharma - Products, Competitors, Financials, Employees ...
Dec 9, 2013 Oncolys BioPharma is a bioventure company that develops pharmaceuticals for cancer and serious infectious diseases. The company engages in research, development, …See details»
Oncolys BioPharma, Inc. (Oncolys BioPharma, Inc.) - 药物管线_专 …
了解Oncolys BioPharma, Inc. (Oncolys BioPharma, Inc.)公司的药物管线，治疗领域，技术平台，以及它的10项临床试验, 6篇新闻和66篇文献，疾病领域:肿瘤，内分泌与代谢疾病，神经系 …See details»
ONCOLYS BIOPHARMA INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ONCOLYS BIOPHARMA INC. of MINATO-KU, TOKYO. Get the latest business insights from Dun & …See details»
Oncolys BioPharma - Contacts, Employees, Board Members
Oncolys BioPharma is a bio-venture that develops breakthrough therapy and diagnostics in cancer treatment from early to late stage. ... Log In. Experience the new Crunchbase, powered …See details»
Corporate Philosophy - About | Oncolys BioPharma Inc.
Our mission is to contribute to the advancement of medical science in the world, by bringing innovation to the existing treatments for cancer and serious infectious diseases, leveraging our …See details»
Explainer | China is working on oncolytic virus therapies. They …
1 day ago Could a US$140 injection shrink aggressive tumours, reawaken the immune system and even extend the life of a late-stage cancer patient? That is the potential of oncolytic virus …See details»